Comparison

Ticagrelor (Brilinta,AZD6140)

Item no. DCC-DC1101-100mg
Manufacturer DCChemicals
CASRN 274693-27-5
Amount 100 mg
Quantity options 100 mg 1 g 250 mg
Category
Type Inhibitors
Applications IC
Specific against other
Purity >98%
Smiles O[C@H]1[C@@H](O)[C@H](N2N=NC3=C(N[C@H]4[C@H](C5=CC=C(F)C(F)=C5)C4)N=C(SCCC)N=C32)C[C@@H]1OCCO
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias AZD-6140,Ticagrelor ,Brilinta,AZD 6140
Similar products 274693-27-5
Available
Manufacturer - Applications
Ticagrelor is the first reversibly binding oral P2Y12 receptor antagonist, also inhibits CYP2C9 and 4-hydroxylation with IC50 of 10.5 μM and 8.2 μM respectively.
Molecular Weight
522, 568
Chemical name
1, 2-Cyclopentanediol, 3-[7-[[(1R, 2S)-2-(3, 4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1, 2, 3-triazolo[4, 5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S, 2S, 3R, 5S)-

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close